HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treating liver cirrhosis in dogs with hepatocyte growth factor gene therapy via the hepatic artery.

AbstractBACKGROUND/PURPOSE:
Liver cirrhosis, an irreversible result of chronic liver disease, has had no effective therapy except liver transplantation. We previously reported successful therapy of liver cirrhosis in rats using the hepatocyte growth factor gene. We presently performed hepatocyte growth factor gene therapy in dogs with liver cirrhosis to examine the feasibility for clinical use.
METHODS:
Liver cirrhosis was established in beagles by administrating dimethylnitrosamine. Naked human hepatocyte growth factor gene or naked LacZ gene was injected repeatedly into livers via the hepatic artery using a porter catheter in dogs with cirrhosis.
RESULTS:
Human hepatocyte growth factor gene expression was detected in livers by immunohistochemical staining and an enzyme-linked immunosorbent assay. Serum liver function test results improved with hepatocyte growth factor gene therapy, which also inhibited hepatic transforming growth factor-beta1expression and reversed fibrosis in cirrhotic liver, improving survival of the dogs.
CONCLUSION:
As naked hepatocyte growth factor gene therapy via the hepatic artery proved simple, safe, and effective in larger animals with cirrhosis, this therapy may be clinically applicable.
AuthorsKiyoshi Horiguchi, Tadamichi Hirano, Takahiro Ueki, Kazuhide Hirakawa, Jiro Fujimoto
JournalJournal of hepato-biliary-pancreatic surgery (J Hepatobiliary Pancreat Surg) Vol. 16 Issue 2 Pg. 171-7 ( 2009) ISSN: 1436-0691 [Electronic] Japan
PMID19221688 (Publication Type: Journal Article)
Chemical References
  • Hepatocyte Growth Factor
  • Dimethylnitrosamine
Topics
  • Animals
  • Dimethylnitrosamine
  • Disease Models, Animal
  • Dogs
  • Enzyme-Linked Immunosorbent Assay
  • Genetic Therapy (methods)
  • Genetic Vectors
  • Hepatic Artery
  • Hepatocyte Growth Factor (pharmacology)
  • Liver Cirrhosis, Experimental (therapy)
  • Liver Function Tests
  • Male
  • Plasmids
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: